---UP---

Nov 9 (Reuters) - Theravance Biopharma Inc and partner Mylan NV on Friday won U.S. regulatory approval for their treatment for a chronic lung condition...


10
Thanks for voting


Daily Mail

15 Related Articles from 2018-11-09